However, additional data was gathered with the knockout mice that indicated that while AOD9604 did not lead to significant weight loss or increase in lipolysis without the beta(3)-adrenergic receptors, there was an increase in energy expenditure and fat oxidation
The results of this study do not suggest GLP-1 receptor agonist medications should supplant evidence-based treatments for binge eating disorder, including cognitive behavioral therapy, she said, noting that this is currently the primary treatment method
Tipps, um ein Nhrstoffdefizit zu verhindern Gerade wenn du weniger isst oder dein Appetit zurckgeht, lohnt es sich, bewusster auf die Qualitt deiner Nhrstoffzufuhr zu achten
Most GLP-1 medications are administered via subcutaneous injection, typically in the abdomen, thigh, or upper arm